| __timestamp | CymaBay Therapeutics, Inc. | Insmed Incorporated |
|---|---|---|
| Wednesday, January 1, 2014 | 15823000 | 56292000 |
| Thursday, January 1, 2015 | 17026000 | 74277000 |
| Friday, January 1, 2016 | 15941000 | 122721000 |
| Sunday, January 1, 2017 | 18938000 | 109749000 |
| Monday, January 1, 2018 | 58124000 | 145283000 |
| Tuesday, January 1, 2019 | 83837000 | 131711000 |
| Wednesday, January 1, 2020 | 35882000 | 181157000 |
| Friday, January 1, 2021 | 64542000 | 272744000 |
| Saturday, January 1, 2022 | 67995000 | 397518000 |
| Sunday, January 1, 2023 | 80118000 | 571011000 |
Unleashing the power of data
In the competitive landscape of biotechnology, research and development (R&D) spending is a critical indicator of a company's commitment to innovation. Over the past decade, Insmed Incorporated and CymaBay Therapeutics, Inc. have demonstrated contrasting trajectories in their R&D investments. From 2014 to 2023, Insmed's R&D expenses surged by over 900%, peaking in 2023 with a staggering 571 million dollars. This reflects Insmed's aggressive strategy to expand its therapeutic pipeline. In contrast, CymaBay's R&D spending grew by approximately 400% during the same period, reaching 80 million dollars in 2023. This more measured increase suggests a focused approach to developing niche therapies. The data highlights the dynamic nature of R&D strategies in the biotech sector, where companies balance risk and innovation to drive future growth.
Comparing Innovation Spending: Novo Nordisk A/S and CymaBay Therapeutics, Inc.
Comparing Innovation Spending: Pfizer Inc. and Insmed Incorporated
Research and Development Investment: Vertex Pharmaceuticals Incorporated vs CymaBay Therapeutics, Inc.
Zoetis Inc. vs Insmed Incorporated: Strategic Focus on R&D Spending
R&D Spending Showdown: GSK plc vs Insmed Incorporated
Biogen Inc. or Insmed Incorporated: Who Invests More in Innovation?
Research and Development Investment: Viatris Inc. vs CymaBay Therapeutics, Inc.
Selling, General, and Administrative Costs: Insmed Incorporated vs CymaBay Therapeutics, Inc.
Analyzing R&D Budgets: Insmed Incorporated vs CRISPR Therapeutics AG
Who Prioritizes Innovation? R&D Spending Compared for Insmed Incorporated and Supernus Pharmaceuticals, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Opthea Limited and CymaBay Therapeutics, Inc.
Comparing Innovation Spending: CymaBay Therapeutics, Inc. and Catalyst Pharmaceuticals, Inc.